Total Payments
$48,979
2024 Payments
$1,036
Companies
28
Transactions
422
Medicare Patients
2,715
Medicare Billing
$414,801
Payment Breakdown by Category
Other$34,520 (70.5%)
Food & Beverage$8,625 (17.6%)
Consulting$3,251 (6.6%)
Travel$2,352 (4.8%)
Education$230.58 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $34,520 | 23 | 70.5% |
| Food and Beverage | $8,625 | 369 | 17.6% |
| Consulting Fee | $3,251 | 4 | 6.6% |
| Travel and Lodging | $2,352 | 12 | 4.8% |
| Education | $230.58 | 14 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $15,917 | 73 | $0 (2024) |
| Merck Sharp & Dohme LLC | $12,722 | 79 | $0 (2024) |
| Theravance Biopharma, Inc. | $7,290 | 23 | $0 (2018) |
| Allergan, Inc. | $4,770 | 70 | $0 (2020) |
| Insmed, Inc. | $3,629 | 17 | $0 (2023) |
| Organogenesis Inc. | $1,327 | 19 | $0 (2023) |
| CSL Behring | $1,294 | 49 | $0 (2024) |
| ViiV Healthcare Company | $479.71 | 26 | $0 (2024) |
| Smith+Nephew, Inc. | $375.14 | 15 | $0 (2024) |
| KCI USA, Inc. | $279.22 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,036 | 41 | CSL Behring ($262.29) |
| 2023 | $6,787 | 48 | Insmed, Inc. ($3,536) |
| 2022 | $5,506 | 50 | ABBVIE INC. ($5,041) |
| 2021 | $9,002 | 53 | AbbVie Inc. ($8,295) |
| 2020 | $5,042 | 50 | Allergan, Inc. ($4,517) |
| 2019 | $5,467 | 72 | Merck Sharp & Dohme Corporation ($4,304) |
| 2018 | $8,560 | 36 | Merck Sharp & Dohme Corporation ($5,971) |
| 2017 | $7,578 | 72 | Theravance Biopharma Inc. ($5,124) |
All Payment Transactions
422 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $29.16 | General |
| Category: GI | ||||||
| 12/12/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/26/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $36.32 | General |
| Category: Immunology | ||||||
| 11/13/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: HIV | ||||||
| 11/07/2024 | La Jolla Pharmaceutical Company | XERAVA (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 10/22/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $21.06 | General |
| Category: HIV | ||||||
| 10/09/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: VIROLOGY | ||||||
| 10/02/2024 | Smith+Nephew, Inc. | GRAFIX PL (Medical Supply) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Other Advanced Wound Management | ||||||
| 10/01/2024 | La Jolla Pharmaceutical Company | XACDURO (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/19/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/17/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/12/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Food and Beverage | In-kind items and services | $23.38 | General |
| Category: ANTIFUNGALS | ||||||
| 09/10/2024 | Smith+Nephew, Inc. | COLLAGENASE SANTYL (Drug) | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: Pharma Products | ||||||
| 09/03/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $35.38 | General |
| Category: Immunology | ||||||
| 08/20/2024 | Shionogi Inc | Fetroja (Drug) | Food and Beverage | In-kind items and services | $32.14 | General |
| Category: Infections and Infectious Diseases | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | PIFELTRO (Drug), DELSTRIGO | Education | In-kind items and services | $10.85 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $22.32 | General |
| 07/18/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $29.78 | General |
| Category: GI | ||||||
| 07/16/2024 | Merck Sharp & Dohme LLC | DIFICID (Drug), RECARBRIO, ZERBAXA | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/09/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $26.81 | General |
| Category: HIV | ||||||
| 06/21/2024 | ABBVIE INC. | TEFLARO (Drug), AVYCAZ, DALVANCE | Food and Beverage | In-kind items and services | $33.80 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/18/2024 | CSL Behring | Hizentra (Biological) | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Immunology | ||||||
| 06/12/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $20.23 | General |
| Category: VIROLOGY | ||||||
| 06/12/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: ANTIBIOTIC | ||||||
| 05/23/2024 | Melinta Therapeutics, LLC | Rezzayo (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: ANTIFUNGALS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 588 | 1,215 | $201,598 | $78,589 |
| 2022 | 7 | 596 | 1,298 | $216,467 | $96,962 |
| 2021 | 8 | 781 | 1,761 | $286,559 | $130,661 |
| 2020 | 10 | 750 | 1,555 | $231,605 | $108,588 |
Total Patients
2,715
Total Services
5,829
Medicare Billing
$414,801
Procedure Codes
40
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 189 | 412 | $49,028 | $25,662 | 52.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 118 | 119 | $35,700 | $16,017 | 44.9% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2023 | 61 | 237 | $63,516 | $11,089 | 17.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 61 | 166 | $19,920 | $8,600 | 43.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 56 | 82 | $12,546 | $7,448 | 59.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 15 | 57 | $9,690 | $4,358 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 68 | $8,160 | $4,113 | 50.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 12 | 12 | $1,980 | $765.17 | 38.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 26 | $338.00 | $218.40 | 64.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 12 | 16 | $400.00 | $165.60 | 41.4% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 16 | 20 | $320.00 | $152.20 | 47.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 162 | 168 | $48,300 | $27,601 | 57.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 197 | 471 | $54,495 | $26,890 | 49.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 105 | 223 | $33,095 | $19,209 | 58.0% |
| 11042 | Removal of skin and tissue, 20.0 sq cm or less | Facility | 2022 | 35 | 183 | $49,044 | $8,534 | 17.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 41 | 141 | $16,595 | $7,141 | 43.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 13 | 40 | $6,709 | $3,102 | 46.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 19 | 37 | $4,365 | $2,549 | 58.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 22 | $3,705 | $1,898 | 51.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 11 | 13 | $159.00 | $38.43 | 24.2% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 268 | 706 | $78,486 | $40,739 | 51.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 209 | 221 | $60,775 | $37,349 | 61.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 121 | 268 | $38,584 | $23,832 | 61.8% |
| 11042 | Removal of skin and tissue first 20 sq cm or less | Facility | 2021 | 53 | 289 | $77,452 | $13,692 | 17.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 57 | 154 | $17,662 | $8,105 | 45.9% |
About Dr. Steven Bobula, MD
Dr. Steven Bobula, MD is a Infectious Disease healthcare provider based in Westerville, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/24/2007. The National Provider Identifier (NPI) number assigned to this provider is 1700097565.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Bobula, MD has received a total of $48,979 in payments from pharmaceutical and medical device companies, with $1,036 received in 2024. These payments were reported across 422 transactions from 28 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($34,520).
As a Medicare-enrolled provider, Bobula has provided services to 2,715 Medicare beneficiaries, totaling 5,829 services with total Medicare billing of $414,801. Data is available for 4 years (2020–2023), covering 40 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Westerville, OH
- Active Since 05/24/2007
- Last Updated 07/25/2018
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1700097565
Products in Payments
- AVYCAZ (Drug) $12,501
- DIFICID (Drug) $12,295
- VIBATIV (Drug) $7,290
- DALVANCE (Drug) $4,731
- TEFLARO (Drug) $3,327
- Arikayce (Drug) $3,304
- Hizentra (Biological) $1,269
- Puraply (Medical Supply) $491.43
- Apligraf (Biological) $355.14
- DOVATO (Drug) $316.41
- Puraply Antimicrobial (Medical Supply) $254.95
- Apligraf (Device) $225.18
- ZERBAXA (Drug) $192.60
- GRAFIX PL (Medical Supply) $182.12
- ISENTRESS (Drug) $130.34
- VAC VERAFLO (Device) $126.72
- CABENUVA (Biological) $112.91
- MAVYRET (Drug) $112.47
- COLLAGENASE SANTYL (Drug) $101.38
- Orbactiv (Drug) $96.80
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Westerville
Jane Emerick, M.d, M.D
Infectious Disease — Payments: $5,479
Infectious Disease $5,479
Dr. Sunil Bhat, Md, MD
Infectious Disease — Payments: $2,897
Infectious Disease $2,897
Johnny Huh, M.d, M.D
Infectious Disease — Payments: $2,182
Infectious Disease $2,182
Timothy Anderson, Md, MD
Infectious Disease — Payments: $1,491
Infectious Disease $1,491
Wael Haidar, Md, MD
Infectious Disease — Payments: $340.27
Infectious Disease $340.27